1. Home
  2. VALU vs RZLT Comparison

VALU vs RZLT Comparison

Compare VALU & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Value Line Inc.

VALU

Value Line Inc.

N/A

Current Price

$33.14

Market Cap

311.5M

Sector

Finance

ML Signal

N/A

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$3.29

Market Cap

321.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VALU
RZLT
Founded
1931
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
311.5M
321.6M
IPO Year
1995
2011

Fundamental Metrics

Financial Performance
Metric
VALU
RZLT
Price
$33.14
$3.29
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$9.67
AVG Volume (30 Days)
1.0K
1.3M
Earning Date
03-16-2026
05-13-2026
Dividend Yield
3.72%
N/A
EPS Growth
8.91
26.32
EPS
1.92
N/A
Revenue
$36,257,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$17.34
N/A
Revenue Growth
1.08
N/A
52 Week Low
$32.73
$1.07
52 Week High
$40.50
$11.46

Technical Indicators

Market Signals
Indicator
VALU
RZLT
Relative Strength Index (RSI) 38.46 51.42
Support Level N/A $2.93
Resistance Level $38.26 $3.60
Average True Range (ATR) 0.47 0.21
MACD -0.04 0.00
Stochastic Oscillator 17.57 62.38

Price Performance

Historical Comparison
VALU
RZLT

About VALU Value Line Inc.

Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and a trusted name in Investment Research. Its only operating segment being Publishing.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Share on Social Networks: